139 related articles for article (PubMed ID: 8892605)
1. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
[TBL] [Abstract][Full Text] [Related]
2. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells.
Gonzalez-Garcia A; R-Borlado L; Leonardo E; Merida I; Martinez-A C; Carrera AC
J Immunol; 1997 May; 158(9):4104-12. PubMed ID: 9126969
[TBL] [Abstract][Full Text] [Related]
3. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
4. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity.
Fang N; Motto DG; Ross SE; Koretzky GA
J Immunol; 1996 Nov; 157(9):3769-73. PubMed ID: 8892604
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
6. T cell antigen receptor-induced IL-2 production and apoptosis have different requirements for Lck activities.
Chung CD; Lewis LA; Miceli MC
J Immunol; 1997 Aug; 159(4):1758-66. PubMed ID: 9257838
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
8. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
10. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner.
Won J; Hur YG; Hur EM; Park SH; Kang MA; Choi Y; Park C; Lee KH; Yun Y
Eur J Immunol; 2003 Apr; 33(4):870-9. PubMed ID: 12672052
[TBL] [Abstract][Full Text] [Related]
11. The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway.
Ngai J; Methi T; Andressen KW; Levy FO; Torgersen KM; Vang T; Wettschureck N; Taskén K
Eur J Immunol; 2008 Nov; 38(11):3208-18. PubMed ID: 18991294
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.
Latinis KM; Carr LL; Peterson EJ; Norian LA; Eliason SL; Koretzky GA
J Immunol; 1997 May; 158(10):4602-11. PubMed ID: 9144472
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
14. Th2-specific immunity and function of peripheral T cells is regulated by the p56Lck Src homology 3 domain.
McCoy ME; Finkelman FD; Straus DB
J Immunol; 2010 Sep; 185(6):3285-94. PubMed ID: 20729329
[TBL] [Abstract][Full Text] [Related]
15. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.
He X; Woodford-Thomas TA; Johnson KG; Shah DD; Thomas ML
Eur J Immunol; 2002 Sep; 32(9):2578-87. PubMed ID: 12207342
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
Rapecki S; Allen R
J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
[TBL] [Abstract][Full Text] [Related]
18. Regulation of gamma T-cell antigen receptor expression by intracellular calcium in acute lymphoblastic leukemia cell line DND41.
Peralta-Zaragoza O; Martínez-Valdez H; Madrid-Marina V
Arch Med Res; 1996; 27(3):305-10. PubMed ID: 8854386
[TBL] [Abstract][Full Text] [Related]
19. Local regulation of immune responses: corneal endothelial cells alter t cell activation and cytokine production.
Mi P; Gregerson DS; Kawashima H
Cytokine; 2000 Mar; 12(3):253-64. PubMed ID: 10704253
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A-resistant transactivation of the IL-2 promoter requires activity of okadaic acid-sensitive serine/threonine phosphatases.
Nebl G; Meuer SC; Samstag Y
J Immunol; 1998 Aug; 161(4):1803-10. PubMed ID: 9712047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
